Our Liver Organoids Technology Platform
Ace Therapeutics leverages the mature organoid platform to simulate physiological and pathological states of the liver in vitro, demonstrating significant value in elucidating disease pathways, enhancing drug screening, and improving efficacy assessment.
Applications of Liver Organoid Models
For Drug Screening
The faithful preservation of the original tumor's genetic and pathological characteristics creates a model that mirrors human disease heterogeneity, thus providing a platform for personalized drug screening.
For Drug Hepatotoxicity Evaluation
Our liver organoid model enables the evaluation of drug hepatotoxicity and metabolism, allowing for more accurate prediction of in vivo liver toxicity and metabolic behavior.
Pathogenesis Research of Liver Tumors
Our liver organoid model offers a high-fidelity representation of the liver TME, complete with stage-specific inflammation and angiogenesis, thereby advancing the study of liver tumors and therapeutic efficacy.
Ace Therapeutics leverages its gut microbiome analysis platform to evaluate drug efficacy for therapies targeting gastrointestinal and liver diseases.
Ace Therapeutics specializes in preclinical gastroenterology and hepatology research. With expertise in disease model customization, pathology research, drug development, and more, we offer comprehensive solutions to advance scientific discoveries.